GlassScriptPhysician profile
James Buchino
NPI 1366689168
$4,292.22
in general payments reported to CMS, 2019-2025
14 companies · $486 in 2025
The $486 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $1,588 · 2021: $87.30 · 2022: $216 · 2023: $94.89 · 2024: $1,374 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Travel and Lodging: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.15 |
| Travel and Lodging | $799.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,289.64 | 2019-2025 | Obsidio, Embold Fibered, Angiojet Ultra 5000a |
| Philips North America LLC | $1,250.00 | 2020 | |
| Penumbra, INC. | $247.66 | 2020-2022 | |
| Sirtex Medical INC | $135.82 | 2020-2025 | Lava Les (Liquid Embolic System) |
| Medtronic, INC. | $114.21 | 2021-2025 | Concertotm, Kyphon Express II Kyphopak Tray |
| Medtronic Vascular, INC. | $84.90 | 2019 | |
| Argon Medical Devices, INC. | $29.67 | 2024 | Clot Management |
| Genentech USA, INC. | $27.13 | 2025 | Itovebi |
| Bard Peripheral Vascular, INC. | $25.36 | 2019 | |
| Cordis US Corp. | $23.85 | 2021 | |
| Glaxosmithkline, LLC. | $18.90 | 2020 | |
| Bracco Diagnostics INC. | $17.69 | 2025 | |
| Trisalus Life Sciences, INC. | $14.70 | 2025 | Trinav Infusion System |
| Ge Healthcare | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Buchino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.